chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient. A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Dec2020 as dose 1, single (Batch/Lot number: unknown), in left arm, on 12Jan2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 07Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 67 years, in left arm for Covid-19 immunisation. The patient's relevant medical history included: "Thyroid cancer" (unspecified if ongoing). Concomitant medication(s) included in 2weeks: LEVOTHYROXINE. Adverse event: Rebound COVID symptoms and + COVID test one week after completing Paxlovid. Had negative COVID test after completing Paxlovid. Known allergies: No. The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of vaccination failure, Covid-19. Anti-viral details: Product: COVID 19 Treatment Brand: Paxlovid treatment start date: 19Apr2022 treatment stop date: 24Apr2022 indication: Treatment of COVID-19. No treatment for adverse events. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received. Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of the reported events cannot be totally excluded.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Oct2021 as dose 3 (booster),  single (Batch/Lot number: unknown) at the age of 28 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: NIKKI taken for contraception. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete: unknown manufacturer), for COVID-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 30Apr2022, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (30Apr2022) Positive. It was unknown if therapeutic measures were taken as a result of drug ineffective, covid-19.  clinical course was reported as: 1 week after stopping Paxlovid, patient became symptomatic with milder symptoms and tested positive again for COVID-19 on a home test. No known allergies reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: Gotten COVID-19; gotten COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (176967). The reporter is the patient.  A female patient received BNT162b2 (COMIRNATY), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "gotten COVID-19".  Clinical course: Reporter stated she had gotten COVID-19 after being vaccinated with the Pfizer covid-19 vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were not taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Mar2021 as dose 1, single (Batch/Lot number: unknown) and on 04Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 05Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Clinical information: No Other medication in 2 weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: felt fatigued; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunization; Bnt162b2 (Dose 2), for Covid-19 Immunization; Bnt162b2 (Dose 3), for Covid-19 Immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "felt fatigued".  Additional information: Reporting information during a dinner event this evening and hearing from an attendee that after recently receiving her second Pfizer/BioNTech COVID-19 vaccine booster (approximately 2 weeks ago), she felt fatigued (which did not happen from her first 3 shots of the Pfizer/BioNTech COVID-19 vaccine).   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Malaise
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (the patient). A patient (no qualifiers provided) received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. The patient experienced malaise (I am not really well; I am not well"), and fatigue ("wears me out too much trying to talk"), with outcome of unknown. Additional information: Patient was not really well. It wore them out too much trying to talk. Patient was not well and having trouble understanding. Reporter type could not be probed over the call hence captured as consumer or other non-healthcare professional by default. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information  expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Raynaud's phenomenon
Clinical narrative: This is a spontaneous report received from a contactable reporter (nurse). The reporter is the patient. A 31-year-old male patient received bnt162b2 (BNT162B2) on 23Nov2021 as dose 3 (booster), single (Lot number: FH8028), at the age of 31 years, in left arm for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: Unknown; Anatomical Location: Left Arm), administration date: 20Jan2021, when the patient was 31 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: EM9809; Anatomical Location: Left Arm), administration date: 10Feb2021, when the patient was 31 years old, for COVID-19 immunisation. The following information was reported: RAYNAUD'S PHENOMENON (non-serious) with onset 01Dec2021, outcome "recovered with sequelae", described as "Raynaud's Disease". Therapeutic measures were not taken as a result of RAYNAUD'S PHENOMENON. Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, SARS-CoV-2 test, Vaccination failure
Clinical narrative: He tested positive for COVID on 03May and has only minor congestion.; He tested positive for COVID on 03May and has only minor congestion.; minor congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 50-year-old male patient received BNT162b2 (BNT162B2), on 26Feb2021 as dose 1, single (Lot number: EN6205), on 20Mar2021 as dose 2, single (Lot number: EN6204) and on 06Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 50 years for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "High blood pressure and cholesterol" (unspecified if ongoing), notes: High blood pressure and cholesterol; "asthma" (unspecified if ongoing); "High blood pressure and cholesterol" (unspecified if ongoing), notes: High blood pressure and cholesterol. Concomitant medication(s) included: LISINOPRIL; ATORVASTATIN. The following information was reported: NASAL CONGESTION (non-serious) with onset 01May2022, outcome "not recovered", described as "minor congestion"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 03May2022, outcome "not recovered" and all described as "He tested positive for COVID on 03May and has only minor congestion.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03May2022) Positive, notes: Nasal Swab covid test name post vaccination: Binax. Therapeutic measures were not taken as a result of vaccination failure, covid-19, nasal congestion. Facility type vaccine reported as Pharmacy or Drug Store. If other vaccine in four weeks reported as no. Other medications in two weeks reported as Lisinopril, Atorvastatin. If covid prior vaccination reported as no. If covid tested post vaccination reported as yes. Known allergies reported as no.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report received from a non-contactable reporter (Consumer or other non-HCP). The reporter is the patient. A 35-year-old female patient (not pregnant) received bnt162b2 (BNT162B2) on 05Apr2022 as dose 1, single (Lot number: unknown), at the age of 35 years, in the left arm for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes. The patient did not receive any concomitant medications. The following information was reported: HEART RATE INCREASED (non-serious) with onset 03May2022, outcome "not recovered", described as "Fast heartbeat occurred 4 weeks after". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of the heart rate increased. Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: patient tested positive today, 04May2022, for COVID-19; patient tested positive today, 04May2022, for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL9264), on 20Feb2021 as dose 2, single (Lot number: EL9266) and on 10Oct2021 as dose 3 (booster), single (Lot number: FH8020) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04May2022, outcome "unknown" and all described as "patient tested positive today, 04May2022, for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04May2022) Positive, notes: patient tested positive today, 04May2022, for COVID-19. Clinical course: Patient tested positive today, 04May2022, for COVID-19. Patient had previously been vaccinated and boosted with the Pfizer BNT vaccine. Event took place after use of product.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Headache, Insomnia, Oropharyngeal pain, Pyrexia
Clinical narrative: patient tested positive today, 04May2022, for COVID-19; patient tested positive today, 04May2022, for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL9264), on 20Feb2021 as dose 2, single (Lot number: EL9266) and on 10Oct2021 as dose 3 (booster), single (Lot number: FH8020) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04May2022, outcome "unknown" and all described as "patient tested positive today, 04May2022, for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04May2022) Positive, notes: patient tested positive today, 04May2022, for COVID-19. Clinical course: Patient tested positive today, 04May2022, for COVID-19. Patient had previously been vaccinated and boosted with the Pfizer BNT vaccine. Event took place after use of product.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: patient tested positive today, 04May2022, for COVID-19; patient tested positive today, 04May2022, for COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL9264), on 20Feb2021 as dose 2, single (Lot number: EL9266) and on 10Oct2021 as dose 3 (booster), single (Lot number: FH8020) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 04May2022, outcome "unknown" and all described as "patient tested positive today, 04May2022, for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (04May2022) Positive, notes: patient tested positive today, 04May2022, for COVID-19. Clinical course: Patient tested positive today, 04May2022, for COVID-19. Patient had previously been vaccinated and boosted with the Pfizer BNT vaccine. Event took place after use of product.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old male patient received BNT162b2 (BNT162B2), on 29Oct2021 as dose 3 (booster), single (Lot number: fg3527) at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown). The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; ZINC; LORATADINE; ATORVASTATIN CALCIUM, stop date: 19Apr2022; AMLODIPINE BENAZEPRIL. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01May2022) Negative; (03May2022) Positive; (2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical Course: The patient received COVID 19 Treatment (Brand: Paxlovid), from 19Apr2022 to 24Apr2022. It was further reported that on friday 29Apr2022, the patient started to feel similar COVID symptoms returned (sore throat). He tested negative with an at home rapid test. The symptoms continued and I tested negative on 01May. on 03May I started with a cough and congestion. The patient tested positive with a rapid at home test.  No follow-up attempts are possible. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: She died reactions from the COVID Shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 72-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "She died reactions from the COVID Shot". The patient date of death was unknown. Reported cause of death: "She died reactions from the COVID Shot". Clinical information: "I have two, have some friend, two of our friends, one was 51 the other one 72, post night after they had the COVID shot, one had a heart attack and the other one, she was told totally healthy, she run five miles a day, only walk five miles a day, never had nothing wrong with her, she died reactions from the COVID Shot." No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: She died reactions from the COVID Shot
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal abscess, Constipation, Mesenteric vein thrombosis, SARS-CoV-2 antibody test
Clinical narrative: SMV/IMV thrombosis; constipation; bacteria filled abscess in abdomen; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the parent.  A 65-year-old male patient received BNT162b2 (BNT162B2), on 11Oct2021 at 13:15 as dose 3 (booster), single (Lot number: FF2590) at the age of 65 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not listed on medical record, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 31Mar2021, when the patient was 64-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EN6208, Location of injection: Arm Left, Vaccine Administration Time: 02:30 PM, Route of Administration: Other), administration date: 17Mar2021, when the patient was 64-year-old, for COVID-19 immunization. The following information was reported: MESENTERIC VEIN THROMBOSIS (hospitalization, medically significant, life threatening) with onset 01Nov2021, outcome "not recovered", described as "SMV/IMV thrombosis"; ABDOMINAL ABSCESS (hospitalization, medically significant, life threatening) with onset 01Nov2021, outcome "not recovered", described as "bacteria filled abscess in abdomen"; CONSTIPATION (hospitalization, life threatening) with onset 01Nov2021, outcome "not recovered". The patient was hospitalized for mesenteric vein thrombosis, constipation, abdominal abscess (hospitalization duration: 20 day(s)). The events "smv/imv thrombosis", "constipation" and "bacteria filled abscess in abdomen" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (03May2022) Negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of mesenteric vein thrombosis, constipation, abdominal abscess.  Clinical Course: The patient tested for covid post vaccination. no known allergies and no other medications were received with in two weeks of covid vaccination.; Sender's Comments: Based on the information provided there is a reasonable possibility of causal association between the events with the suspect product bnt162b2.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of consciousness, Seizure, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Seizure-Medium, Additional Details: Patient passed out while sitting in post vaccine area.  The first person who saw the patient reported he appeared to be seizing briefly. Patient was conscious but somewhat disoriented when I made it to him.  EMS came and transported patient to hospital for evaluation.
Age: 82.0
Sex: F
Vaccine: PPV
Symptoms: Asthenia, Chest discomfort, Chest pain, Dizziness, Fatigue
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Weakness-Medium
Age: 82.0
Sex: F
Vaccine: PPV
Symptoms: Lethargy, Pain, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Weakness-Medium
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Mild
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pain
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Back pain, Computerised tomogram, Injected limb mobility decreased
Clinical narrative: On or about March 25, 2022, I experienced extreme pain and stiffness on the right side of my upper body.  I was unable to turn my head towards my shoulder, the right side of my neck, the right upper back, shoulder and arms hurt with constant shooting and throbbing pains.  The pain subsided, then the weakness started.  I could not lift my right arm to shoulder level.  When I was finally able to lift my arm to shoulder level, my muscles in that arm would fatigue and my arm would lower.  I went to the ER for evaluation for a stroke.  At the ER, I was told that I had not had a stroke, but I needed to follow up with my primary care physician.  The ER doctor placed me on a week long tapering dose of steroids, which alleviated the pain, but did very little for the weakness.  I followed up with my primary care physician, who referred me to an orthopedic surgeon.  The orthopedic surgeon sent me to a neurologist for a nerve conduction study.  The orthopedic surgeon informed me that I had all the symptoms of Parsonage-Turner Syndrome.  I am now on a regime of a tapering dose of steroids for seven weeks, and an anti-convulsant/nerve pill for the pain until the orthopedic surgeon discontinues.  The pain has subsided tremendously, but my right arm is still weak.  My daughter and I noticed that this incident regarding my arm happened in the arm in which I took the vaccine.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Muscle fatigue, Muscular weakness, Musculoskeletal stiffness, Neck pain
Clinical narrative: On or about March 25, 2022, I experienced extreme pain and stiffness on the right side of my upper body.  I was unable to turn my head towards my shoulder, the right side of my neck, the right upper back, shoulder and arms hurt with constant shooting and throbbing pains.  The pain subsided, then the weakness started.  I could not lift my right arm to shoulder level.  When I was finally able to lift my arm to shoulder level, my muscles in that arm would fatigue and my arm would lower.  I went to the ER for evaluation for a stroke.  At the ER, I was told that I had not had a stroke, but I needed to follow up with my primary care physician.  The ER doctor placed me on a week long tapering dose of steroids, which alleviated the pain, but did very little for the weakness.  I followed up with my primary care physician, who referred me to an orthopedic surgeon.  The orthopedic surgeon sent me to a neurologist for a nerve conduction study.  The orthopedic surgeon informed me that I had all the symptoms of Parsonage-Turner Syndrome.  I am now on a regime of a tapering dose of steroids for seven weeks, and an anti-convulsant/nerve pill for the pain until the orthopedic surgeon discontinues.  The pain has subsided tremendously, but my right arm is still weak.  My daughter and I noticed that this incident regarding my arm happened in the arm in which I took the vaccine.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve conduction studies, Neuralgic amyotrophy, Pain, Pain in extremity, X-ray
Clinical narrative: On or about March 25, 2022, I experienced extreme pain and stiffness on the right side of my upper body.  I was unable to turn my head towards my shoulder, the right side of my neck, the right upper back, shoulder and arms hurt with constant shooting and throbbing pains.  The pain subsided, then the weakness started.  I could not lift my right arm to shoulder level.  When I was finally able to lift my arm to shoulder level, my muscles in that arm would fatigue and my arm would lower.  I went to the ER for evaluation for a stroke.  At the ER, I was told that I had not had a stroke, but I needed to follow up with my primary care physician.  The ER doctor placed me on a week long tapering dose of steroids, which alleviated the pain, but did very little for the weakness.  I followed up with my primary care physician, who referred me to an orthopedic surgeon.  The orthopedic surgeon sent me to a neurologist for a nerve conduction study.  The orthopedic surgeon informed me that I had all the symptoms of Parsonage-Turner Syndrome.  I am now on a regime of a tapering dose of steroids for seven weeks, and an anti-convulsant/nerve pill for the pain until the orthopedic surgeon discontinues.  The pain has subsided tremendously, but my right arm is still weak.  My daughter and I noticed that this incident regarding my arm happened in the arm in which I took the vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Adnexa uteri pain, Biopsy soft tissue, Dysmenorrhoea, Postmenopausal haemorrhage, Ultrasound scan normal
Clinical narrative: The following day, day 2 of vaccination. I started experiencing sharp stabbing pain in my ovaries.  The pain was like I never felt before, so sharp that it would make me jump and scream due to the fast and sharp pain.  On day 4, the sharp pain continued and menstrual cramps started (both pains are very different).  On this day at night, I started bleeding like a regular menstrual period ( which I have not had in +4yrs due to menopause).  The bleeding, cramps and sharp pain continued for 3 weeks. Then 2nd dose was on 4/20 which caused same cycle but not as sharp the pain and less cramps and bleeding.  AND NOW I constantly (weekly) get cramps and sharp pain with sporadic blood spotting.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site erythema, Injection site mass, Injection site pruritus, Injection site scab
Clinical narrative: Red, lumpy with black bruising on arm at injection site after 2nd day. Lumps and black bruising went away after first week but still have a red bull eye with scabbing at injection entrance after almost a month. Also injection site is itchy.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Skin warm, Swelling
Clinical narrative: Raised, swollen, red area that is hot to the touch.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Pain in armpit of arm that shot was given
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, UNK
Symptoms: Erythema, Rash pruritic
Clinical narrative: Red skin across breast, at first looked like sunburn. After about a month rash had spread all across mid section back and shoulders- extremely itchy
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Mobility decreased, X-ray of pelvis and hip
Clinical narrative: Started with severe pain in my hip, unable to lift my leg, bend or walk normally. Went to Dr on 4/27 sent for x-rays. Nothing outstanding, thought it may have been bursitis. Several days later I got severe shoulder pain in both shoulders. I had been using Tylenol, Advil and using a portable ultrasound machine with little relief. Then I got severe pain in my knee...it was weird, it seemed to change locations. This was NOT typical arthritis pain, but something much different. I am going to the orthopedist on 5/9 to seek some relief.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Chest pain, Cold sweat, Diarrhoea, Dyspnoea
Clinical narrative: I woke up paralyzed.  I couldn't move, see or talk.  I had extreme pain in my body, particularly in my chest.  I had difficulty breathing.  I thought I was going to die.  Then, I'm guessing 20 minutes later, I was finally able to move and I made my way to the bathroom where I had a lot of diarrhea.  When I got back to bed I was having cold sweats.  I was exhausted and all I could do was get back into bed.  I realized now that my husband should have taken me to the emergency room.  But he didn't think of it and I was too exhausted to do anything other than sleep.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Paralysis, Speech disorder
Clinical narrative: I woke up paralyzed.  I couldn't move, see or talk.  I had extreme pain in my body, particularly in my chest.  I had difficulty breathing.  I thought I was going to die.  Then, I'm guessing 20 minutes later, I was finally able to move and I made my way to the bathroom where I had a lot of diarrhea.  When I got back to bed I was having cold sweats.  I was exhausted and all I could do was get back into bed.  I realized now that my husband should have taken me to the emergency room.  But he didn't think of it and I was too exhausted to do anything other than sleep.
Age: 61.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Pain upon moving arm; joint pain throughout; fever; headache; nausea
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: Severe chills, body aches, headache, fatigue.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Antinuclear antibody positive, Hypoaesthesia, Nerve conduction studies normal, Paraesthesia, Small fibre neuropathy
Clinical narrative: Starting in January, I experienced intermittent numbness/tingling in my fingers and toes. I saw a neurologist who indicated I had small fiber neuropathy in my hands and feet extending up to about my knees. The test she performed on my feet and legs in her office with a metal instrument indicated I could not feel cold up to my knee.  These symptoms seem to have resolved.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Thyroxine free increased
Clinical narrative: Starting in January, I experienced intermittent numbness/tingling in my fingers and toes. I saw a neurologist who indicated I had small fiber neuropathy in my hands and feet extending up to about my knees. The test she performed on my feet and legs in her office with a metal instrument indicated I could not feel cold up to my knee.  These symptoms seem to have resolved.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dry throat, Hypoaesthesia, Product after taste, Swollen tongue
Clinical narrative: Pt complained of swollen tongue, tasting "medicine" at the back of throat, numbness, dry throat, 10-15 min after getting the vaccine, was asked if she wanted an epipen adminstered but declined, she accepted a water bottle but said it did not help with the dryness, when asked if she wanted 911 called she said yes and emt was called to the pharmacy, upon EMT arrival she was still conscious and able to talk, complained of weakness when escorted to ambulance.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac stress test normal, Echocardiogram normal, Electrocardiogram abnormal, Electrocardiogram ambulatory abnormal, Extrasystoles
Clinical narrative: Heart palpations, Bigimeny, extra beats
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular, Palpitations, Stress echocardiogram, Supraventricular tachycardia
Clinical narrative: Heart palpations, Bigimeny, extra beats
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered 3 days outside of BUD date - no reactions/signs/symptoms reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above vaccine given beyond  10 week expiration date.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Condition aggravated, Headache, Hypertension, Injection site erythema, Injection site pain
Clinical narrative: Headache, HTN exacerbation, tachycardia, injection site redness and pain
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Tachycardia
Clinical narrative: Headache, HTN exacerbation, tachycardia, injection site redness and pain
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Contraception, Dizziness, Heavy menstrual bleeding, Pain in extremity
Clinical narrative: Sore arm, off and on severe menstrual bleeding even during times when I have never had a period. I do not have menstrual cycles and after receiving my first, second, and booster shots I have now been having severe menorrhagia, bleeding to the point of faintness and having to use adult diapers, etc. I've spend well over 1000$ on feminine products and to replace ruined clothing. Birth control has done nothing to keep the bleeding at bay either.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial flutter, Blood test, Cardiac ablation, Cardioversion, Echocardiogram
Clinical narrative: Atrial Flutter treated by Cardioversion and Catheter Ablation
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, X-ray
Clinical narrative: Atrial Flutter treated by Cardioversion and Catheter Ablation
Age: 64.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Decreased appetite, Fatigue, Pyrexia
Clinical narrative: extreme chills, fever, total exhaustion, loss of appetite
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Expired product administered
Clinical narrative: Patient and parent came in for patient?s 4 Month physical and vaccines.  Patient was inadvertently given an expired dose of Pentacel, which is a combination of Dtap, IPV, and HIB.   The expiration date was 3/12/2022. Other vaccines given were Prevnar (PCV) and Rota Virus (RotaTeq), which were both current.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Vaccination error
Clinical narrative: VACCINE ADMINISTERED OUTSIDE OF EAU PATIENT HAD MILD FLU-LIKE SYMPTOMS AFTER ADMINISTRATION
Age: 36.0
Sex: F
Vaccine: HEPA, TDAP
Symptoms: Headache, Pain in extremity, Peripheral swelling, Pyrexia, Tissue injury
Clinical narrative: Patient began to have fever, headache, arm swelling on 5/4/22. Then presented with deep tissue injury and arm pain that began on 5/6/22 .
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fall, Presyncope, Pyrexia
Clinical narrative: Fever on days 2 and 3 with painful joints and back pain. Fell on day 2 after vomiting and almost blacked out
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting
Clinical narrative: Fever on days 2 and 3 with painful joints and back pain. Fell on day 2 after vomiting and almost blacked out
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above vaccine given beyond 10 week expiration date.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Full body aching starting in arm and neck but also in legs and hips
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 65.0
Sex: M
Vaccine: VARZOS
Symptoms: Insomnia, Myalgia, Pain in extremity
Clinical narrative: sorness in vaccine arm along with mussle aches. I then experienced not being able to sleep the last 2 nights
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer vaccine administered 3 days outside of BUD date - no reactions/signs/symptoms reported
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer vaccine administered outside of BUD date - no reactions/signs/symptoms reported
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Oedema, Oedema peripheral, Pain in extremity, Pleurisy
Clinical narrative: Rash all over, edema, fever 103.  Prednisone resolved temporarily.  Renewed rash, intermittent fever, chills, vomiting, itching, edema in extremeties, pleurisy, fluid in lungs, ground-glass images in lungs.    I don't know if any of this is related to the vaccine.    I have since had Moderna vaccines on 4/6/2021, 10/22/2021 and 4/4/2022.  My arm was sore for a few days after each shot, but I did not experience any other immediate symptoms.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pulmonary oedema, Pyrexia, Rash, Vomiting
Clinical narrative: Rash all over, edema, fever 103.  Prednisone resolved temporarily.  Renewed rash, intermittent fever, chills, vomiting, itching, edema in extremeties, pleurisy, fluid in lungs, ground-glass images in lungs.    I don't know if any of this is related to the vaccine.    I have since had Moderna vaccines on 4/6/2021, 10/22/2021 and 4/4/2022.  My arm was sore for a few days after each shot, but I did not experience any other immediate symptoms.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Pain in extremity, Peripheral swelling
Clinical narrative: Pain to upper arm, numbness to the tip of left hand?s fingers,  numbness to  mouth lower lips and swollen /pain to  left arm armpit.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Above Vaccine given beyond 10 week expiration date
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Echocardiogram abnormal, Ejection fraction decreased, No adverse event
Clinical narrative: No adverse events, only out come was elevated BNP levels detected during blood test for life insurance test
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: 2ND BOOSTER, 4TH OVERALL DOSE OF PFIZER COVID-19 VACCINE PRESENTED WITH BODY ACHES, LOW GRADE FEVER AND HEADACHE OCCURING WITHIN 12 HOURS POST-VACCINATION
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Dizziness, Fatigue, Palpitations
Clinical narrative: heart palpitation - ongoing. This is second shot, and the first shot in January heart palpitation lasted for 2 months - did not think about adverse effect of the vaccine until the heart palpitation returns again after the second shot. Also have diziness, and fatigure symptoms, but the worst is frequent heart palpitation.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Pain, Periarthritis
Clinical narrative: Had frozen right shoulder with severe pain and discomfort for 9 days after shot
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hemiparesis, Injected limb mobility decreased, Injection site pain, Insomnia, Muscular weakness
Clinical narrative: Constant pain in area of injection site; some limited movement and pain with movement; some weakness in left arm; sometimes painful to sleep on left arm; physical therapy has not helped; no prior injury or problems with left arm or shoulder
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, X-ray
Clinical narrative: Constant pain in area of injection site; some limited movement and pain with movement; some weakness in left arm; sometimes painful to sleep on left arm; physical therapy has not helped; no prior injury or problems with left arm or shoulder
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Patient experienced blisters on her toes and feet, she explained to me she thought it was from her boot because she has tendonitis, but then a day later discovered the blisters on her foot without the boot. She saw the podiatrist and he said to monitor the blisters and do not pop them. I advised her the same advise. She will follow up with her doctor on Monday this week. I saw the blisters and they look exactly like subepidermal blistering eruptions, possibly due to mRNA vaccine administration.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Parkinson's disease, Pyrexia
Clinical narrative: Patient described having fatigue, fever, malaise, chills, and extreme Parkinson movements/shaking/trembling that prevent the patient from even holding a temporal thermometer or holding any object. The patient had to go lay down and wait for the shaking to stop.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Patient described having fatigue, fever, malaise, chills, and extreme Parkinson movements/shaking/trembling that prevent the patient from even holding a temporal thermometer or holding any object. The patient had to go lay down and wait for the shaking to stop.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Eye pain, Vision blurred
Clinical narrative: Patient experienced blurred vision in one eye 1 day after vaccination that was transient.  It was associated with mild pain with extra ocular movements.  Within 24 hours, the symptoms in that eye resolved, but started in the opposite eye.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Aggression, Blood test, Diarrhoea, Headache
Clinical narrative: 12 days fever 100F or above; stomach ache; diarrhea; headache; insomnia; rash near injection site; itchy '"all over"; fussiness; temper tantrums; lethargy
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Insomnia, Irritability, Lethargy, Pruritus
Clinical narrative: 12 days fever 100F or above; stomach ache; diarrhea; headache; insomnia; rash near injection site; itchy '"all over"; fussiness; temper tantrums; lethargy
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Urine analysis
Clinical narrative: 12 days fever 100F or above; stomach ache; diarrhea; headache; insomnia; rash near injection site; itchy '"all over"; fussiness; temper tantrums; lethargy
Age: 35.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Echocardiogram, Myocarditis, Troponin
Clinical narrative: myocarditis
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Electrocardiogram abnormal, Palpitations
Clinical narrative: Heart palpitations and atrial fibrillation approximately one week after vaccination.
Age: 36.0
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Caesarean section, Dyspnoea, Feeling abnormal, Pain, Premature baby death
Clinical narrative: Patient is a 36 yr/o female who is 34 weeks pregnant complained to her fiancé, that she wasn't feeling quite right after work, having difficulty breathing, and in a lot of pain but did not seek medical attention. The decedent woke husband around 0440 on 02/08 and stated she was having a very hard time breathing and needed to go to the ER. Emergency Services were contacted, while on Tx the decedent went into Respiratory Arrest, By-standard CPR initiated, resuscitate efforts attempted, the decedent was transported to ER, emergency bedside C-section performed, and the decedent was pronounced dead at 0542 by DR.